Jaguar Health files resale prospectus for up to 40.9M shares by selling stockholder; company may receive up to $40M from equity line

Filed August 21, 2026 · ~1 min read

Key Changes

• high

  This is a secondary offering: up to 40,874,552 shares are being resold by selling stockholder C/M Capital Master Fund, LP. Jaguar Health will not receive any proceeds from these resales.

  The Offering verify on EDGAR →
• high

  Separately, the company may receive up to $40 million in aggregate from sales of common stock to C/M Capital under an equity line of credit, subject to market conditions and the company's election to sell.

  The Offering verify on EDGAR →
• high

  The equity line of credit with C/M Capital, established under a common stock purchase agreement dated June 9, 2026, creates potential future dilution for existing shareholders.

  The Offering verify on EDGAR →